MARCH CoE 2024 Summit: Session 4-Addressing Maternal Health Challenges through Data, Programs, & Partnerships

Instructions to Receive Credit

Sunday, December 1, 2024, 8:00 AM - Wednesday, December 1, 2027, 5:00 PM

The Avera Research Institute Maternal Health Research Center of Excellence (MARCH) provides a platform for researchers, tribal nations, rural communities, and key stakeholders to engage in bidirectional communication on maternal health, in particular drivers of mortality and severe morbidity. This recorded session from the MARCH CoE 2024 Summit discusses how the South Dakota Department of Health is addressing maternal health challenges through data, programs, and partnerships.

1. Identify the leading causes of pregnancy-associated deaths.
2. Recognize the data sources used to identify maternal health status in South Dakota.
3. Understand the current South Dakota Department of Health programs and initiatives to improve maternal health.
4. Integrate a multidisciplinary approach into the development of plan of care.

Bibliography

Disclaimer:

All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner.

ADA Statement:
ADA accommodations will be made in accordance with the law.  If you require ADA accommodations, please indicate what your needs are at the time of registration.  We cannot ensure the availability of appropriate accommodations without prior notification.

---

This education opportunity is provided by the Avera Research Institute, Maternal American Indian Rural Community Health Center of Excellence and is supported by grant award [U54-HD113179, PI: Elliott]. The MARCH Center of Excellence provides a platform for researchers, tribal nations, rural communities, and key stakeholders to engage in bidirectional communication on maternal health. Contact Avera Research Institute at [email protected] email or 605-504-3154 phone number with questions.

In support of improving patient care, Avera is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designations:

	This activity was planned by and for the healthcare team, and learners will receive 0.75 IPCE credits for learning and change.
	Medicine CME:  Avera designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
	Nurse CE: Avera designates this activity for a maximum of 0.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
	SD State Board of SW: Avera Health Provider # is an approved provider of continuing education by the South Dakota Board of Social Work Examiners. Social Workers will receive 0.75 continuing education clock hour(s) for participating in this course
	Counselors, Marriage and Family Therapy (SD Board of Examiners): Avera is a recognized provider of continuing education, for all counseling related content, for the South Dakota Board of Examiners for Counselors and Marriage and Family Therapists. Social Workers will receive 0.75 continuing education clock hour(s) for participating in this course.

Mitigation of Relevant Financial Relationships

Avera adheres to the Joint Accreditation’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.